News
WXIBF
4.600
NaN%
--
Nomura Sticks to Their Buy Rating for Wuxi Biologics (Cayman) (WXIBF)
TipRanks · 19h ago
Weekly Report: what happened at WXIBF last week (0720-0724)?
Weekly Report · 1d ago
Weekly Report: what happened at WXIBF last week (0713-0717)?
Weekly Report · 07/20 09:14
SDIC Securities Keeps Their Buy Rating on Wuxi Biologics (Cayman) (WXIBF)
TipRanks · 07/17 09:55
CLSA Reaffirms Their Buy Rating on Wuxi Biologics (Cayman) (WXIBF)
TipRanks · 07/14 00:25
Weekly Report: what happened at WXIBF last week (0706-0710)?
Weekly Report · 07/13 09:15
Analysts Offer Insights on Healthcare Companies: Wuxi Biologics (Cayman) (OtherWXIBF) and Community Health (CYH)
TipRanks · 07/11 01:50
Weekly Report: what happened at WXIBF last week (0629-0703)?
Weekly Report · 07/06 09:15
UBS Keeps Their Buy Rating on Wuxi Biologics (Cayman) (WXIBF)
TipRanks · 07/04 00:25
Weekly Report: what happened at WXIBF last week (0622-0626)?
Weekly Report · 06/29 09:15
Weekly Report: what happened at WXIBF last week (0615-0619)?
Weekly Report · 06/22 09:17
Weekly Report: what happened at WXIBF last week (0608-0612)?
Weekly Report · 06/15 09:16
WuXi Biologics Wins Full Shareholder Backing at 2026 AGM
TipRanks · 06/10 11:45
Analysts Offer Insights on Healthcare Companies: Senseonics Holdings (SENS) and Wuxi Biologics (Cayman) (OtherWXIBF)
TipRanks · 06/10 00:20
Wuxi Biologics Grants Time-Based Restricted Shares to 21 Employees
TipRanks · 06/09 12:16
Guotai Haitong Sticks to Its Buy Rating for Wuxi Biologics (Cayman) (WXIBF)
TipRanks · 06/09 05:17
Weekly Report: what happened at WXIBF last week (0601-0605)?
Weekly Report · 06/08 09:16
Analysts Are Bullish on Top Healthcare Stocks: Autolus Therapeutics (AUTL), Wuxi Biologics (Cayman) (WXIBF)
TipRanks · 06/03 00:20
CICC Remains a Buy on Wuxi Biologics (Cayman) (WXIBF)
TipRanks · 06/02 05:18
Weekly Report: what happened at WXIBF last week (0525-0529)?
Weekly Report · 06/01 09:17
More
Webull provides a variety of real-time WXIBF stock news. You can receive the latest news about Wuxi Bio through multiple platforms. This information may help you make smarter investment decisions.
About WXIBF
WuXi Biologics (Cayman) Inc is an investment holding company principally engaged in the provision of end-to-end solutions and services for biologics discovery, development and manufacturing to customers involving in biologics industry. The Company mainly operates its business through two segments. The Biologics segment mainly engages in the provision of biologics discovery, development and manufacturing. The WuXi XDC (XDC) segment mainly engages in the provision of contract research, development and manufacturing organization (CRDMO) services for antibody-drug conjugate (ADCs) and various bioconjugates. The Company mainly conducts its business in the domestic and overseas markets.